Abstract
Glioblastoma multiform is the most common and aggressive primary brain tumor. Recent studies have demonstrated the central role of cancer stem cells (CSC) in the genesis of glioblastoma, suggesting that this subpopulation is highly resistant to conventional therapies, one of the factors responsible of the poor prognosis these tumors. Thus, therapies directed against the cancer stem cells …